Mounjaro®
Starting from £179.99/mo
Start journey Learn moreTirzepatide is sold in the UK under the brand name Mounjaro, made by Eli Lilly. That single fact answers most of the confusion around this medicine: there is currently one licensed brand for weight management in the UK, one manufacturer, and one delivery format — a pre-filled once-weekly injection pen. As a prescription-only medicine, Mounjaro is only legally available following a clinical assessment by a qualified prescriber. Learn more about how tirzepatide works.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Tirzepatide has one brand name in the UK: Mounjaro. Eli Lilly, the American pharmaceutical company that developed the medicine, holds the UK marketing authorisation and supplies it through the licensed UK supply chain. If you have seen other names attached to tirzepatide online (particularly Zepbound) it is worth knowing that Zepbound is the US brand name for the same molecule. It does not have a UK marketing authorisation, is not stocked by UK pharmacies, and is not obtainable through any legitimate UK route.
The tirzepatide brand name question comes up constantly because people encounter different terminology depending on where they search. In the UK, the answer is always Mounjaro. The medicine comes as a pre-filled KwikPen, with each pen containing four weekly doses across the six licensed strengths: 2.5, 5, 7.5, 10, 12.5 and 15 mg. The NHS tirzepatide medicines page is a reliable place to check the current licensed details.
There is no generic or off-brand tirzepatide available anywhere in the world right now. Eli Lilly's patent protects the molecule, so any product claiming to be tirzepatide but sold under an unofficial name (or at prices far below the established market) should be treated as a serious red flag.
No. Tirzepatide off-brand or generic versions do not legally exist in the UK, or in any market where it is licensed. The molecule is still under patent, which means only Eli Lilly can manufacture it for commercial sale. Pharmacies that dispense Mounjaro must source it through the authorised supply chain; there is no cheaper, equivalent substitute to reach for.
This matters because counterfeit products labelled as tirzepatide have appeared on social media and through unofficial online sellers. The MHRA has warned publicly (and taken enforcement action, including raiding a UK site producing fake tirzepatide pens in late 2025) about the real danger of these counterfeits. Some fake pens seized in earlier operations contained insulin rather than the medicine on the label. A product claiming to be tirzepatide that arrives without a proper prescription process behind it is not a bargain: it is an unknown substance.
If you want to be certain your medication is genuine, check that the dispensing pharmacy is listed on the GPhC register. That takes under a minute and is the simplest way to confirm a pharmacy is regulated. Read more about the different tirzepatide brands in each market and why only Mounjaro applies in the UK.
When you know tirzepatide's UK brand name is Mounjaro, you can search with more precision and sidestep a lot of misleading content. Queries about what brand is tirzepatide often surface a mix of UK and US results, and the pricing, regulatory status and even the licensed dosing presentations differ substantially between markets. A page discussing Zepbound's US list price, for instance, tells you nothing useful about accessing tirzepatide in the UK.
Mounjaro has NICE approval (TA1026) for weight management in adults with a BMI of 35 or above alongside at least one weight-related condition, with lower BMI thresholds applying for certain ethnic backgrounds under UK guidance. On the private route, the licensed SmPC eligibility (a BMI of 30 or above, or 27 or above with a relevant condition) is what a prescriber works from. The full Mounjaro overview covers eligibility, the titration schedule and what to expect from treatment in detail.
It is also worth understanding how the brand name question intersects with cost. Eli Lilly raised Mounjaro's UK list price substantially from September 2025 (the highest-dose pen's list price moved from around £122 to around £330 per four-week pen) and private market prices typically sit between those figures and higher depending on dose and provider. Our breakdown of the Eli Lilly Mounjaro price increase explains what changed and what it means for private patients. Knowing there is no generic alternative is relevant context: the brand price is, for now, the only price.
In the UK, tirzepatide can be prescribed on the NHS through the phased rollout under NICE TA1026, or privately through a regulated online pharmacy or clinic. NHS access currently has strict eligibility thresholds and varies by area; many people turn to the private route because they do not meet NHS criteria yet or prefer not to wait. Explore the private treatment options available through regulated UK providers.
Through a regulated private service, the route is: a clinical consultation, same-day review by a GPhC-registered prescriber, and dispensing from a GPhC-registered pharmacy. No consultation means no prescription. No prescription means no dispensing. Our team at nume follows exactly that sequence, and our prescribers review each consultation personally, not through automated decision-making. Questions about whether a generic tirzepatide brand exists are common; the short answer is that they do not, and understanding that helps set realistic expectations about pricing and sourcing. If you are considering treatment and want to discuss whether Mounjaro is clinically suitable for you, check your eligibility with our prescribers.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.